BioMarin Pharmaceutical, Inc. (BMRN)

58.95 -1.40 (-2.32%) USD  |  NASDAQ  |  Jan 09, 16:00
58.88 -0.07 (-0.12%) Pre-Market: 09:14
More

BioMarin Pharmaceutical Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade